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Type I iodothyronine deiodinase is a ;50-kDa, inte-
gral membrane protein that catalyzes the outer ring
deiodination of thyroxine. Despite the identification
and cloning of a 27-kDa selenoprotein with the catalytic
properties of the type I enzyme, the composition and the
physical nature of the active deiodinase are unknown.
In this report, we use a molecular approach to deter-
mine holoenzyme composition, the role of the membrane
anchor on enzyme assembly, and the contribution of
individual 27-kDa subunits to catalysis. Overexpression
of an immunologically unique rat 27-kDa protein in
LLC-PK1 cells that contain abundant catalytically ac-
tive 27-kDa selenoprotein decreased deiodination by
;50%, and >95% of the LLC-PK1 derived 27-kDa seleno-
protein was specifically immune precipitated by the an-
ti-rat enzyme antibody. The hybrid enzyme had a molec-
ular mass of 54 kDa and an s20,w of ;3.5 S indicating that
every native 27-kDa selenoprotein partnered with an
inert rat 27-kDa subunit in a homodimer. Enzyme as-
sembly did not depend on the presence of the N-terminal
membrane anchor of the 27-kDa subunit. Direct visual-
ization of the deiodinase dimer showed that the holoen-
zyme was sorted to the basolateral plasma membrane of
the renal epithelial cell.
Type I thyroxine deiodinase (D1,1 EC 3.8.1.4) is the most
abundant member of a family of membrane-bound enzymes
that catalyze the removal of a single iodine atom from thyroid
hormone. D1 generates most of the bioactive T3 found in blood
(1–4) and serves as the essential first step in the molecular
mechanism of thyroid hormone action in vivo.
D1 is a selenoenzyme encoded by an ;2.1-kilobase pair
mRNA and is most abundant in liver, kidney, and thyroid
(1–5). The ;27-kDa enzyme polypeptide (p27) contains the
novel amino acid, selenocysteine (SeC) (5), and this residue is
essential for full catalytic activity (6–8). Whether p27 is cata-
lytically active itself or requires post-translational modification
and/or assembly into a multimeric complex remains to be es-
tablished. Despite uncertainty about its composition and the
physical nature of the catalytically active enzyme, site-directed
mutagenesis, species comparisons, domain substitution, and
limited deletion analysis (9–14) have been used to characterize
some of the functional domains of p27. The p27 polypeptide
contains an uncleaved N-terminal signal/membrane anchor fol-
lowed by an uninterrupted catalytic domain facing the cell
interior (10). Iodothyronine substrate specificity is determined
by amino acids located between residues 40 and 65, as judged
by site-directed mutagenesis, analysis of species-specific differ-
ences in catalytic properties, and amino acid composition, and
by interspecies deletion-substitution analysis (9, 11). In addi-
tion to the presumed membrane anchor and the substrate
specificity domain, the active center is thought to be located
in an ;15 amino acid long region bracketing the SeC residue
(7, 12).
Four D1 amino acid residues (Phe-65, Cys-124, SeC-126, and
His-174) have been identified as essential for substrate speci-
ficity and catalysis (7, 9, 11, 12–14). The roles of Phe-65 in
iodothyronine specificity and of SeC126 in catalysis are well
established (7, 9, 11), whereas the roles of Cys-124 and His-174
in the catalytic reaction are less understood. For example,
replacement of Cys-124 with alanine led to parallel ;2-fold
decreases in the Km for rT3 and in catalytic efficiency when
assayed at a fixed cofactor concentration (15). Determination of
the limiting Michaelis constants using two substrate reaction
kinetics revealed that the Km for rT3 was marginally affected in
the C124A mutant (14, 15), whereas the velocity of the forward
reaction decreased ;2-fold (14, 15), and the thiol cofactor re-
quirement increased by 6–14-fold (14, 15). The mechanism for
these changes in kinetic parameters is unclear. Traditional
chemical modification studies established that histidine(s)
were essential for catalysis (16, 17), and subsequent mutagen-
esis and transient expression studies identified His-174 as one
of these essential residue(s) (13).
However, caution is essential when attempting to assign
functional significance to individual amino acids in an incom-
pletely characterized enzyme. Whereas the direct participation
of any D1 residue that affects catalysis is the first possibility
often considered, it is equally likely that individual amino acid
substitutions can influence D1 activity by indirect means such
as (i) abnormal post-translational processing; (ii) altered fold-
ing of the primary translation product that leads to rapid
degradation; (iii) improper sorting of the mutant p27 in the
Golgi apparatus; and/or (iv) disturbed assembly of a functional
enzyme. Thus, the interpretation of the mechanistic conse-
quences of individual mutations on D1 activity in whole cell
lysates of transiently transfected cells is difficult at best and
cannot identify what molecular events are affected without an
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understanding of the influence of the mutation on enzyme
assembly and processing.
Much of the biochemistry of D1 was established prior to the
cloning of the enzyme using the alkylating substrate analogs,
N-BrAcT4 and N-BrAcT3 (18–21). Affinity labeling studies
done with liver and kidney membrane preparations identified
an ;27-kDa thyroid hormone-binding protein (p27) (19–21)
that was subsequently cloned by functional expression (5). In-
terestingly, molecular sieve chromatography of the detergent-
soluble rat kidney D1 yielded an ;50-kDa functional enzyme
(22), and subsequent work showed that the affinity labeled p27
co-migrated with catalytic activity as an ;54-kDa complex
(23). These data suggested that the catalytically active D1 was
composed of two similarly sized subunits. Whether the func-
tional enzyme is a homodimer of p27 subunits or a heterodimer
formed between p27 and an unknown subunit remains to be
established. The latter possibility cannot be excluded because
kidney-derived cell lines have been used for most, if not all, p27
transient expression studies, and this organ has abundant D1
activity. Thus, it is possible that a 25–30-kDa membrane an-
chor protein found in kidney cells could partner with p27 to
form a functional enzyme.
In this study, we exploited the species differences in the
composition of the C terminus of p27 to characterize the com-
position of catalytically active D1. By using the native D1 found
in a pig renal epithelial cell line (LLC-PK1), we overexpressed
an immunologically unique, catalytically inert S126 mutant of
rat p27 (M4), and we examined the consequences of M4 expres-
sion on D1 subunit assembly, enzyme activity, and subcellular
trafficking. The data show that catalytically active D1 is a
dimer composed of two p27 subunits and that the assembled
enzyme is sorted to the basolateral plasma membrane of renal
epithelial cells.
EXPERIMENTAL PROCEDURES
Materials—All reagents were of the highest purity commercially
available. Restriction endonucleases and DNA-modifying enzymes were
purchased from New England Biolabs (Beverly, MA). The femtomoles of
DNA sequencing and the Altered Sites Mutagenesis kits were obtained
from Promega (Madison, WI). a-35S-dATP (3000 Ci/mmol) and
[a232P]dCTP (800 Ci/mmol) were purchased from PerkinElmer Life
Sciences. 75SeO3
22 (;200 Ci/mmol) was purchased from the University
of Missouri-Columbia Research Reactor Facility (Columbia, MO). L-(39-
or 59-125)I]rT3 was prepared by radioiodination of 3,39-T2 using methods
described previously (24). The 2.1-kilobase pair p27 cDNA (G21; Gen-
BankTM accession number X57999) was the gift of P. R. Larsen, Har-
vard Medical School. Synthetic oligonucleotides were prepared in house
or purchased from Life Technologies, Inc. All iodothyronines were of the
L-configuration and were purchased from Henning Berlin GmbH. Dul-
becco’s modified Eagle’s medium, antibiotics, Hanks’ buffered salt so-
lution, glucose, trypsin, and G418 were obtained from Life Technolo-
gies, Inc.; supplemented bovine calf serum was from HyClone
Laboratories (Boulder, CO); acrylamide and N,N9-methylenebisacryl-
amide were from U. S. Biochemical Corp.; ammonium persulfate and
TEMED were from Bio-Rad; and dithiothreitol was from Calbiochem.
Cell Culture—LLC-PK1 cells were grown in 25-cm2 flasks in a hu-
midified atmosphere of 5% CO2 and 95% air at 37 °C as described
previously (23). Complete Growth Medium was composed of Dulbecco’s
modified Eagle’s medium containing 15 mM sodium bicarbonate, 15 mM
HEPES (pH 7.2), 25 mM glucose, 1 mM sodium pyruvate, 5% (v/v) calf
serum, 50 milliunits/ml penicillin, and 90 mg/ml streptomycin. Cells
were subcultured every 3–5 days by seeding 5 3 104 cells/cm2 into
25-cm2 flasks. Culture medium was changed 3 times weekly.
Mutagenesis—Site-directed mutagenesis was used to inactivate the
catalytic activity of rat p27 by substituting Ser for the active center
SeC. In brief, the 2.1-kilobase pair G21 cDNA was released from pBSK
using KpnI-XhoI and cloned into the mutagenesis shuttle vector, pAL-
TER-1 (Promega, Madison, WI). A 24-mer synthetic oligonucleotide
bracketing the SeC-126 codon (nucleotides 372–396, 59-CAGCTGCAC-
CAGCCCTTCATTTCTT-39) was used to create an SeC-126 3 Ser sub-
stitution (underlined nucleotides) using oligonucleotide-based mu-
tagenesis according to the manufacturer’s instructions. The integrity of
the catalytically inactivated, non-SeC containing the M4 mutant of rat
p27 was confirmed by DNA cycle sequencing of the entire coding region
(nucleotides 7–780), and M4 was subcloned into the KpnI-XhoI site of
the eukaryotic expression vector, pcDNA3. Construct orientation was
confirmed by analytical restriction digestion.
Elimination of the putative extracellular domain and the membrane-
spanning anchor of p27 was done by polymerase chain reaction-based
deletion. All upstream oligonucleotide primers contained a KpnI site for
subcloning and an in-frame Kozak consensus translation initiation site
to ensure adequate expression in mammalian cells. The first 19 amino
acids of p27 that include the putative extracellular domain and 7
residues of the membrane-spanning region were deleted using a 27-mer
oligonucleotide upstream primer (59-GGGTACCATGGCCTTGGAGGT-
GGCTAC-39, nucleotides 65–80 of G21 underlined). The N-terminal 42
amino acids that contain the entire membrane-spanning domain was
deleted using a 29-mer oligonucleotide upstream primer (59-GGGG-
TACCATGGCCATGGGCCAAAAGACC-39, nucleotides 131–150 of G21
underlined). The common downstream primer was a 20-mer oligonu-
cleotide corresponding to nucleotides 895–914 of G21 (59-GCCTC-
CCGGGTAGTTATTTG-39). Polymerase chain reaction was done using
Vent® DNA polymerase (Stratagene, La Jolla CA) for a total of 25 cycles
according to the following temperature profile: 95 °C, 1.0 min; 50 °C, 1.0
min; 72 °C, 3.0 min, with a final 10-min extended incubation at 72 °C.
Polymerase chain reaction products were digested with KpnI to gener-
ate asymmetric ends for subcloning, and gel was isolated on 1.4% low
melt agarose gels and ligated into the KpnI-SmaI-ended pcDNA3-M4.
The N-terminal 19-residue deletion mutant, M4-19, and the N-terminal
42-residue deletion mutant, M4-42, were confirmed by DNA cycle se-
quencing (see below).
Generation of M4-expressing LLC-PK1 Cells—LLC-PK1 cells were
grown in Growth Medium to 60% confluence and transfected with 10 mg
of pcDNA3 (empty vector control) or 10 mg of pcDNA3-M4,
pcDNA3-M4-19, or pcDNA3-M4-42 using cationic liposomes (DOTAP®,
Roche Molecular Biochemicals) according to the manufacturer’s in-
structions. Stable transfectants were selected with 800 mg/ml G418, and
antibiotic-resistant cells were expanded without clonal isolation. Cells
constitutively expressing M4 (S126 cells), M4-19, and M4-42 were
maintained in 200 mg/ml G418 to prevent loss of expression of the
exogenous gene product.
DNA Sequencing—Double-stranded DNA sequencing was done by
the dideoxynucleotide method of Sanger (see Ref. 25) using cycle se-
quencing and iterative primers. All sequence information was con-
firmed by sequencing both strands.
Biosynthetic Labeling of Native p27wt Selenoprotein in S126 Cells—
S126 cells were grown to 90% confluence in 25-cm2 flasks in Complete
Growth medium. Cell monolayers were washed 3 times with serum-free
Dulbecco’s modified Eagle’s medium, and the medium was replaced
with serum-free 75Se labeling medium composed of Dulbecco’s modified
Eagle’s medium supplemented with 25 mM HEPES (pH 7.2), 10 mg/ml
BSA, 10 mg/ml transferrin, 20 mg/ml insulin, 40 nM 75Se (specific radio-
activity, 200 mCi/nmol), and antibiotics. Cellular selenoproteins were
biosynthetically radiolabeled at 37 °C for 48 h. After labeling, cells were
washed free of labeling medium, scraped from the dish, and collected by
centrifugation. Cell pellets were stored at 270 °C until use.
Production of Species-specific, Anti-p27 Antibodies—Comparison of
the p27 from fish to man revealed that the C terminus of p27 shows
species-specific variations, and the rodent p27 contains a C-terminal
extension of 8–12 amino acids (26). This unique feature was exploited to
generate a rodent-specific, anti-p27 antibody. A synthetic peptide cor-
responding to the C-terminal 21 residues of rat p27 (NH2-YEEVRAV-
LEKLCIPPGHMPQF-COOH) was coupled to mollusk hemocyanin and
used to immunize rabbits. An N-terminal tyrosine was included to allow
radioiodination and to facilitate directional coupling of the p27 peptide
to carrier protein by diaminobenzidine condensation. Where indicated,
rodent-specific anti-p27 IgG was purified by affinity chromatography
using a p27 peptide-Affi-Gel affinity matrix. In brief, primary anti-
serum was adsorbed to the p27 peptide-Affi-Gel 10 matrix at 25 °C, and
unbound proteins were removed by repeated washes with 150 mM NaCl,
20 mM sodium phosphate buffer (pH 7.4). Anti-p27 IgG was eluted with
100 mM Hac, and antibody elution was monitored by absorbance at 280
nm. Fractions containing antibody were neutralized by adding 0.1 vol-
ume of 1 M Tris (pH 8.6), pooled, and stored frozen (270 °C) at ;1 mg/ml
IgG until use.
Antibody Characterization—Anti-p27 antibodies were used for im-
munoprecipitation and in a competitive binding assay. Pull-down as-
2 J. L. Leonard, T. J. Visser, and D. M. Leonard, manuscript in
preparation.
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says of M4 and associated proteins were done for 60 min at 4 °C in a
total volume of 100 ml. Precipitation reactions contained 50–100 units
of tDOC-solubilized D1 activity prepared from purified membranes
(23), 100 mM HEPES buffer (pH 8.0), 100 mM NaCl, 0.1 mM PMSF, 5 mM
tDOC, 10 ml of immobilized rProtein ATM beads (RepliGen, Cambridge,
MA), and either preimmune rabbit antisera or anti-rat p27 antisera
(1:100 final dilution). Where indicated, excess C-terminal p27 peptide
(10 mg/ml, final concentration) was added to block antibody-binding
sites. Immune complexes bound to the protein A beads were removed by
centrifugation, and the deiodinase activity remaining in the clarified
supernatant was determined as described below.
M4 expression in LLC-PK1 cells was quantified by a competitive
binding assay. Cell pellets or isolated membrane preparations were
solubilized with either 0.1% Triton X-100 (v/v) or 5 mM tDOC, and the
soluble enzyme preparation was clarified by centrifugation at 14,000 3
g for 30 min at 4 °C. Assays were done in triplicate in a total of 100 ml
containing 100 mM Tris buffer (pH 8.3), 100 mM NaCl, 5 mM tDOC,
10,000 cpm 125I-labeled p27 peptide (specific radioactivity, 100 mCi/
mmol), anti-p27 antisera (1:50,000 final dilution), and detergent ex-
tracts. Incubations were done for 2 h at 4 °C, and immune complexes
were precipitated by addition of goat anti-rabbit antiserum (1:5000
dilution). After an additional 60 min at 4 °C, 400 ml of ice-cold PBS
containing 10 mg/ml BSA was added, and the immune precipitates were
collected by centrifugation. Pellets were counted in a well-type g-coun-
ter. Shown in Fig. 1A is a representative displacement curve comparing
p27 peptide to detergent extracts containing the rodent p27 (rat kidney)
to that pig p27 (LLC-PK1 cells). The minimum detection limit of rodent
p27 is ;3 fmol per assay tube (81 pg of p27/tube), and the maximum
binding capacity of the rabbit anti-rat p27 antisera is 22 nmol of p27/ml
antisera as determined by Scatchard analysis of the binding data.
Construction of GFP-tagged M4 Expression Plasmids—A green fluo-
rescent protein (GFP)-tagged p27 fusion construct (M4GFP) was gener-
ated by appending GFP to the C terminus of M4. In brief, the ;750-base
pair HindIII fragment (containing the M4 mutant of p27-coding se-
quence lacking the C-terminal 11 amino acids) was excised from
pcDNA3-M4, gel-purified, and ligated, in-frame, into the HindIII site of
pEGFP-N1 (CLONTECH, Palo Alto, CA). The fusion construct M4GFP
cDNA was excised with BamHI and NotI and ligated into BamHI-NotI-
ended pcDNA3. The integrity of the fusion construct and expression of
a fluorescent fusion protein were confirmed by transient expression of
the pcDNA3-M4GFP in HEK293 cells and immunoblot analysis using
anti-GFP IgG (CLONTECH, CA).
Photomicroscopy—Cells were seeded onto poly-D-lysine (10 mg/ml)-
coated glass coverslips (22 3 22 mm) and grown to ;60% confluence.
Cells were then fixed with 4% paraformaldehyde and permeabilized
with 0.1% Triton (v/v) in PBS. Similarly, rat kidney slices were fixed
with 4% paraformaldehyde in PBS, embedded in paraffin, and ;4-mm
sections were prepared from the outer cortex. The distribution of p27 in
the renal tubule was determined using affinity-purified, anti-p27 IgG
(0.1 mg/ml). Immune complexes were visualized using a Texas Red-
conjugated goat, anti-rabbit IgG (1:2, 500 final dilution). The distribu-
tion of M4GFP in LLC-PK1 cells was determined by fluorescence micros-
copy. Digital images were captured using a Spot CCD camera (Meyer
Instruments, Inc, Houston, TX) and processed using Adobe Photoshop
software. Photomicrographs shown are representative of 20–30 inde-
pendent fields.
Analytical Procedures—D1 activity was determined in cell lysates by
measuring the release of radioiodide from 10 mM [125I]rT3 (100 cpm/
pmol) at 20 mM dithiothreitol (unless otherwise indicated) in a total
volume of 100 ml. Deiodination reactions were done, in triplicate, in 100
mM potassium phosphate buffer (pH 7.0), 1 mM EDTA, with 10–25 mg of
cell protein and incubated at 37 °C for 10–20 min. Product formation
was measured as described previously (24), and the data are expressed
as units/mg protein where 1 unit equals 1 pmol of I2 released per min.
All experiments were performed at least three times. Statistical
analysis was done by Student’s t test.
RESULTS
Characterization of the Rodent-specific Anti-p27 Antisera—
The characterization of the anti-rat p27 antibody was done
using a competitive binding assay, immunoprecipitation, and
immunocytochemistry as shown in Fig. 1. Detergent-soluble
rat kidney p27 readily displaced 125I-labeled p27 peptide from
the anti-rat p27 antisera (Fig. 1A) yielding a concentration of
p27 of 4 6 1 pmol of p27 per mg of kidney membrane protein
(mean 6 S.E., n 5 3), similar to that reported previously (19,
20). On the other hand, up to 1 mg of LLC-PK1 membrane
protein (;500 units of D1 activity) failed to displace any of the
rat-specific 125I-labeled p27 peptide indicating that the pig p27
selenoprotein was not recognized by the anti-rat p27 antibody.
The ability of the anti-rat p27 antisera to immune precipitate
detergent-soluble D1 activity is shown in Fig. 1B. Detergent-
soluble D1 activity was prepared from rat kidney and LLC-PK1
microsomes (23), and the clarified extracts were incubated with
anti-p27 antibody in the absence or presence of excess blocking
peptide. All (.98%) of the soluble D1 activity from rat kidney
membranes was lost from the detergent extracts when the
FIG. 1. Characterization of the epitope-directed anti-rat p27
antisera. A, competitive binding analysis of p27 peptide, detergent-
soluble rat kidney membranes, and detergent-soluble LLC-PK1 cell
membranes. Cell and membrane preparations were solubilized with
0.1% Triton X-100 or 5 mM tDOC. Assays were done as described under
“Experimental Procedures.” Data are reported as the means of closely
agreeing triplicate determinations. l , p27 peptide; f, rat Mx; E, LLC-
PK1 Mx. B, immune precipitation of D1 activity from solubilized rat
kidney membranes (rat Mx) and solubilized LLC-PK1 (PK1 Mx) mem-
branes. Microsomes were prepared from rat kidney and LLC-PK1 cells.
Catalytically active D1 was solubilized with 5 mM tDOC, and 2 mg of
soluble Mx protein (150 units of D1 activity) was incubated in triplicate
with a 1:100 dilution of anti-rat p27 antisera in the absence (filled bars)
and presence (open bars) of 10 mg/ml blocking peptide at 4 °C for 60 min.
D1 activity remaining in the supernatant after removal of specific
immune complexes by protein A beads was determined as described
under “Experimental Procedures.” Data are reported as means 6 S.E. of
three independent microsome preparations. C, representative photomi-
crographs of immunoreactive p27 in rat kidney tubules from selenium-
supplemented and selenium-deficient rats. PCT, proximal convoluted
tubule; G, glomerulus. Bar 5 50 mm.
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immune complexes were removed with protein A-Sepharose,
and addition of a 200-fold molar excess of p27 peptide com-
pletely blocked the antibody-dependent loss of D1 activity. As
expected from the failure of the LLC-PK1-derived p27 to dis-
place the rat p27 peptide from the anti-rat p27 antibody, no
soluble D1 activity was immune precipitated from microsomes
isolated from LLC-PK1 cells. Shown in Fig. 1C are represent-
ative photomicrographs of rat renal cortex from selenium-re-
plete and selenium-deficient rats stained with the anti-rat p27
antisera. Selenium-dependent expression of the abundant im-
munoreactive protein is found in cells lining a subset of tubules
that surround the glomerulus, consistent with earlier subcel-
lular localization studies (23, 27). These data establish that the
anti-rat p27 antiserum shows species-specific recognition of the
rat p27 selenoprotein by immunoprecipitation, competitive dis-
placement analysis, and by immunocytochemistry.
Analysis of the Effects of Constitutive Expression of M4 on
Native D1 Activity in LLC-PK1 Cells—The abundant D1 activ-
ity in LLC-PK1 cells was used previously to characterize both
the biochemistry and physiochemical properties of the enzyme
(23, 28). Gel filtration and isopycnic density gradient centrifu-
gation of detergent-soluble D1 from these cells showed that
catalytic activity and the BrAcT4-labeled p27 co-migrated as a
globular protein with a Mr of ;54,000 (28), suggesting that D1
is a dimer of two similarly sized subunits, presumably p27.
Shown in Fig. 2 are the potential combinations of p27 subunits
that can form in LLC-PK1 cells that constitutively express the
catalytically inert M4 mutant of rat p27 (S126 cells). Combi-
nations I and II yield dimers with at least one selenoprotein
partner. Overexpression of the M4 protein relative to the na-
tive p27wt selenoprotein will also generate immunoreactive,
nonselenoprotein dimers of M4 (combination III), and these
dimers are favored if the rat-derived, M4 mutant cannot inter-
act with the native p27wt in LLC-PK1 cells. Only combination
II yields a D1 dimer composed of a native p27wt selenoprotein
partnered with M4, and this hybrid D1 can be rescued with
antibodies directed against the rat p27.
Shown in Fig. 3 are the results of pull-down assays done with
anti-rat p27 antibody and soluble D1 from control (vector) and
S126 cells. Little, if any, detergent-soluble 75Se-labeled p27
was specifically bound to the protein A beads when normal
rabbit serum was used (Fig. 3A, left bars). In contrast, ;10% of
the total 75Se-labeled protein(s) solubilized from S126 cells was
specifically immune precipitated by the anti-rat p27 antibody,
whereas the quantity of 75Se-labeled proteins from the vector
cells bound to the protein A beads was identical to the nonspe-
cific binding found when normal rabbit serum was used (Fig.
3A). Addition of a 200-fold molar excess of blocking peptide
decreased the quantity of 75Se-labeled S126 cell protein bound
to the anti-rat p27 antibody to that nonspecifically bound to the
protein A beads.
Shown in Fig. 3B is the companion analysis of the effects of
anti-rat p27 antibody on soluble D1 activity prepared from
microsomes isolated from vector and S126 cells. Similar to the
results obtained with soluble 75Se-labeled p27 prepared from
vector and S126 cells, ,5% of the soluble D1 activity was lost in
the pull-down assay when normal rabbit serum was used, and
the addition of excess blocking peptide had no effect on D1
activity. Interestingly, the D1 activity in S126 cells was ;50%
of that found in the vector control, LLC-PK1 cell. Just as
observed with the soluble D1 activity from rat kidney and
untransfected LLC-PK1 cells (see Fig. 1B), little, if any, soluble
D1 activity in vector cells was removed by immune precipita-
tion with anti-rat p27 antisera. In contrast, .95% of the D1
activity in detergent extracts of S126 cells was removed by the
anti-rat p27 antibody, and this loss in activity was blocked by
addition of excess p27 peptide (Fig. 3B). By comparing the
quantity of soluble D1 remaining in the supernatant in the
presence of excess blocking peptide with that found when nor-
mal rabbit serum was used revealed that $97% of the starting
FIG. 2. Potential combinations of p27 molecules in LLC-PK1
cells constitutively expressing the Ser-126 mutant (M4) of rat
p27.
FIG. 3. Immunoprecipitation of D1 holoenzyme composed of
pig p27wt-M4 dimers by anti-rat p27 antisera. A, immune precipi-
tation of 75Se-labeled proteins. LLC-PK1 cells that constitutively ex-
press the neor gene (vector cells) or the M4 mutant of p27 (S126 cells)
were grown in 75Se-labeling media for 48 h as described under “Exper-
imental Procedures.” Cell membranes were prepared, and 25,000 cpm
75Se-labeled protein was incubated with protein A beads, 6 anti-rat p27
IgG in the absence (open bars) and presence (filled bars) of excess
blocking peptide as described in the legend to Fig. 1B. B, immune
precipitation of D1 activity. The ability of anti-rat-p27 antisera to
immunoprecipitate tDOC-soluble D1 from vector and S126 cell micro-
somes was done as described in the legend to Fig. 1B. Data are reported
as means 6 S.E., n 5 3 independent preparations.
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D1 activity in the S126 cell was protected from antibody deple-
tion by the blocking peptide. These findings show that overex-
pression of the catalytically inert M4 protein markedly reduced
the catalytic potential of the native D1 in the host LLC-PK1 cell
and yielded a “hybrid” D1 that was specifically precipitated by
anti-rat p27 antibodies. The data also suggest that the assem-
bly of a catalytically active D1 is a post-translational event.
Direct identification of hybrid D1 dimers composed of the
non-selenoprotein M4 and the native p27wt selenoprotein is
shown in Fig. 4. The native p27 selenoprotein in control LLC-
PK1 cells and in S126 cells was biosynthetically radiolabeled
with 75Se, and detergent extracts of the radiolabeled cells in-
cubated with anti-rat p27 antibody and the specific immune
complexes were separated on 12.5% SDS-PAGE gels. Shown in
Fig. 4 are representative fluorograms of the 75Se-labeled pro-
teins in starting cell lysates (lanes 1 and 3) and in immune
precipitates (lanes 2 and 4) of control LLC-PK1 cells (lanes 1
and 2) and S126 cells (lanes 3 and 4). Whereas M4 overexpres-
sion had little, if any, influence on the quantity of 75Se-labeled
p27 found in S126 cell lysates (compare lanes 1 and 3), the
native 75Se-labeled p27 co-immunoprecipitated with M4 from
the S126 cell (lane 4) but was not immune precipitated from the
parent LLC-PK1 cells (lane 2). Since only the native p27 can
incorporate 75Se into the polypeptide, these data confirm that
the native LLC-PK1-derived p27 subunit was partnered with a
rat M4 polypeptide in the S126 cell. Together with the data
showing that specific M4-directed antibodies removed .97% of
the D1 activity from the S126 cell, these data show that over-
expression of the inert M4 leads to the quantitative formation
of a catalytically impaired, hybrid D1 enzyme composed of pig
p27wt-M4 partners.
We then measured the quantities of both the native p27wt
and M4 mutant proteins in the S126 cells by exploiting the
selenium-dependent expression of the p27wt and the unique
immunoreactivity of M4. S126 cells were grown in the absence
and presence of 40 nM 75Se for 48 h, and cell lysates were
prepared. Selenium-deficient S126 cells lost .93% of the hybrid
D1 activity when compared with control selenium-supplemented
S126 cells (Table I). Although the 75Se-labeled p27wt was com-
pletely lost in selenium-deficient cells, the cellular content of M4
was unaffected by changes in selenium content. Estimates of the
p27wt and M4 content in selenium-supplemented S126 cells (Ta-
ble I) showed that there is an ;10-fold molar excess of M4 over
the native p27wt, and based on the data in Fig. 3 and in Table I
this appears to be sufficient to complex most, if not all, of the
native p27wt present in the S126 cell (Table I).
Physiochemical Properties of the Hybrid D1 Composed of
p27wt-M4 Partners in S126 Cells—To determine whether the
catalytically active hybrid D1 composed of p27wt-M4 partners
was a dimer or a higher order aggregate, detergent extracts of
75Se-labeled S126 cells were separated by isopycnic density
gradient centrifugation (28), and the sedimentation properties
of the 75Se-labeled p27wt-M4 partners were determined by im-
mune precipitation. The distribution of 75Se-labeled p27wt-M4
complexes peaked between the marker proteins carbonic anhy-
drase and BSA as shown in Fig. 5. Assuming a frictional ratio
(f/f0) of 0.85 equal to that determined for BrAcT4-labeled p27
(28), the sedimentation coefficient (s20,w) for the
75Se-labeled
hybrid D1 (p27wt-M4 complex) is ;3.5, yielding a calculated
mass of 54 kDa in close agreement with previous estimates of
the native D1 (28). These data confirm that the catalytically
active hybrid D1 in S126 cells is a dimer composed of one p27wt
and one M4 subunit.
The Role of the Membrane Anchor in D1 Holoenzyme Assem-
bly—Since the D1 holoenzyme is a dimer of two membrane-
spanning p27 subunits and assembly of the enzyme is a post-
translational event, we examined the role of the membrane
anchor in D1 holoenzyme assembly. Earlier work suggested
that the N terminus of p27 was required for either proper
post-translational processing or that specific residues located
in this region were necessary for catalysis. Two basic residues
in the N terminus of p27 appear to be required for proper
folding of the p27 (10). To explore the role of the membrane
anchor of p27 in D1 assembly, we prepared N-terminal deletion
mutants of M4 in which the “external” 12 amino acids, includ-
ing two basic residues at position 11 and 12, and 7 residues in
the membrane-spanning region were removed (M4-19), and/or
the entire membrane anchor was deleted (M4-42). Constitutive
overexpression of these truncation mutants in LLC-PK1 cells
was done as described for the parent M4 and yielded two new
cell lines, M4-19 and M4-42.
Shown in Fig. 6, are the consequences of expression of M4-19
and M4-42 on D1 activity. As observed with the parent M4,
overexpression of either truncation mutation decreased D1 ac-
tivity by ;50%, and 90–95% of the D1 activity present in the
M4-19 and M4-42 cells was immunoprecipitated by the anti-rat
p27 antibody. These data indicate that a catalytically active D1
holoenzyme can be formed from dimers of the native p27wt and
a truncated p27 that lack the entire membrane anchor. From
these data it appears that assembly of the D1 holoenzyme does
not require both p27 subunits to be membrane-associated.
Catalytic Consequences of Hybrid D1 Holoenzyme Composed
of p27wt and Inactive Subunits—Since the D1 activity in the
S126 cell was derived from a holoenzyme composed of p27wt-M4
FIG. 4. Representative fluorograms of SDS-PAGE analysis of
anti-rat p27 immune precipitates from control LLC-PK1 cells or
M4-expressing S126 cells. Immune precipitates were prepared as
described under “Experimental Procedures,” denatured by heating at
100 °C for 5 min, and separated on 12.5% SDS-PAGE cells under
reducing conditions as described previously (23). Proteins were resolved
by SDS-PAGE, and the distribution of 75Se-labeled proteins was deter-
mined by PhosphorImager. Lane 1, LLC-PK1 cell lysate; lane 2, im-
mune precipitate from LLC-PK1 cells; lane 3, S126 cell lysate; lane 4,
immune precipitate from S126 cells.
TABLE I
Summary of the D1 activity, M4, and p27wt content in S126 cells
M4 content was determined by competitive binding assay as de-
scribed under “Experimental Procedures” using 125I-labeled peptide as
the tracer. Wild type p27 content was determined by measuring the
quantity of 75Se-labeled native p27 in S126 cells after radiolabeling to
equilibrium and SDS-PAGE analysis. 1 unit of D1 activity 5 1 pmol I2
released/min. ND, not detected (,0.001 pmol/mg protein). Data are
reported as means 6 S.E., n 5 3.
Growth conditions
No 75Se 40 nM 75Se
D1 activity
(units/mg protein) 1.5 6 0.2 19.1 6 3.1
M4
(pmol/mg protein) 1.7 6 0.2 1.6 6 0.30
p27wt
(pmol/mg protein) ND 0.17 6 0.03
Molar ratio
M4/p27wt .1000 9.4
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subunits, and M4-M4 dimers are catalytically inert, we used
the hybrid D1 activity in S126 cells to examine the influence of
each subunit on the catalytic reaction. Hybrid D1 activity was
provided by S126 cell lysates, and two-substrate reaction ki-
netics were done as detailed previously (24, 29). As shown in
Fig. 7, both wild type D1 activity in LLC-PK1 cells and the
hybrid D1 activity derived from p27wt-M4 dimers in S126 cells
showed the expected ping-pong reaction kinetics. Secondary
replots of slopes and intercepts versus the reciprocal of the thiol
cofactor concentration yielded the limiting kinetic constants of
the respective D1 holoenzyme (Table II). Although the limiting
Km values for the thiol cofactor and iodothyronine were either
unchanged or marginally affected when one of the p27 subunits
was catalytically inert, there was a marked 75% reduction in
the maximal forward velocity of the deiodination reaction of the
hybrid D1 when compared with that of the wild type D1.
Subcellular Distribution of M4GFP-M4GFP Dimers and p27wt-
M4GFP Dimers in S126 Cells—Finally, we exploited the fact
that the C terminus of p27 is degenerate, to generate a fluo-
rescent p27-green fluorescent protein reporter molecule (GFP)
fusion protein (M4GFP) that allows the D1 holoenzyme to be
followed in the living cell. GFP was appended in-frame to the C
terminus of M4, and constitutive expression of the M4GFP fu-
sion protein in LLC-PK1 cells led to the appearance of abun-
dant membrane-bound fluorescence (Fig. 8). D1 activity in the
M4GFP-expressing cells showed a marked decrease (45
units/mg protein in control LLC-PK1 cells versus 18 units/mg
protein in M4GFP-expressing cells) similar to that observed
when M4 alone was introduced into the LLC-PK1 cell (see Fig.
FIG. 5. Migration of D1 holoenzyme composed of p27wt-M4 in
5–20% linear sucrose gradients in H2O. D1 holoenzyme was labeled
with 75Se and solubilized from S126 cells (solid line) and control LLC-
PK1 cells (dotted line) with 5 mM tDOC as described under “Experi-
mental Procedures.” One mg of solubilized protein was sedimented on
individual gradients as described previously (22, 28). Carbonic anhy-
drase (CA) and BSA were added internal standard proteins and iden-
tified on stained SDS-PAGE gels on individual fractions. 75Se-labeled
protein associated with M4 was immune precipitated with anti-rat p27
antisera as described under “Experimental Procedures” and counted in
a well-type g2counter. Data are representative of 3 separate gradients.
FIG. 6. Effects of the N-terminal membrane anchor of p27 on
assembly of catalytically active D1 holoenzyme. N-terminal trun-
cation mutants (M4-19 and M4-42) were prepared as described under
“Experimental Procedures” and transfected into LLC-PK1 cells, and
stable transfectants were selected with 800 mg/ml G418. Cell mem-
branes were prepared and immunoprecipitated with anti-rat p27 anti-
sera (1:100 final dilution) as described in the legend to Fig. 1B. Data
reported as means 6 S.E. n 5 3 independent membrane preparations.
Also shown are the putative p27 domains remaining in each truncation
mutant. A, membrane anchor; C, catalytic domain.
FIG. 7. Initial velocity reaction kinetics for D1 activity in con-
trol LLC-PK1 cells carrying the empty pcDNA3 vector (D1 wild
type) and in S126 cells (M4). Steady-state reaction kinetics were
done as described previously (24, 29). The hybrid D1 holoenzyme was
obtained from the S126 cells detailed in Table I, and the enzyme
concentration was assumed to be equal to that of the native p27 (;0.2
pmol/mg cell protein). E, 1.0; l , 1.67; f, 2.5; , 5; l, 20 mM dithiothre-
itol (DTT). Intercept replots: E, wild type D1; M, S126 D1. Data are
representative of 3 separate studies. All lines were drawn by least
squares linear regression analysis.
TABLE II
Limiting kinetic constants for wild type D1 and the hybrid D1 in
S126 cells
Molar activity 5 mol product z min21 z mol D1 holoenzyme21. Data
reported as means 6 S.E., n 5 3 for separate determinations. DTT,
dithiothreitol.
D1 dimer
composition
Limiting Km
Molar activity
rT3 DTT
mM mM
p27wt-p27wt 0.5 7.5 1780 6 100
p27wt-M4 0.2 7.5 447 6 40
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3). These findings show that addition of the GFP reporter to the
C terminus of M4 did not impair the ability of M4 to form
hybrid D1 dimers with the native p27wt subunit. To ensure that
the D1 activity present in the M4GFP-expressing cells was
derived from a hybrid D1 holoenzyme composed of native p27wt
and M4GFP subunits, anti-GFP antibodies were used in a pull-
down assay. As expected, anti-GFP IgG did not precipitate the
D1 activity in control LLC-PK1 cell extracts but specifically
immunoprecipitated .95% of the D1 activity in M4GFP-ex-
pressing cells (data not shown). These findings show that over-
expression of the inert D1 subunit, M4GFP, results in the for-
mation of a catalytically active D1 holoenzyme composed of a
p27wt and M4GFP subunits and that the appended GFP re-
porter had little, if any, influence on the deiodination reaction
of the complex.
Shown in Fig. 8 are representative photomicrographs of the
distribution of the M4GFP-derived D1 holoenzyme in LLC-PK1
cells constitutively expressing this fusion protein (M4GFP cells).
Abundant punctate florescent signals were found between the
boundaries of adjacent cells and along the cell periphery of
individual cells. Infrequently, a more diffuse fluorescent signal
is observed in the perinuclear space. These data are consistent
with earlier studies showing that the BrAcT4-labeled native
p27wt was sorted to the basolateral membranes in the oriented
LLC-PK1 cell (23, 27, 30) and indicate that the M4GFP fusion
protein, whether as a homodimer or a mixed wild type p27:
M4GFP, is also directed to the basolateral plasma membrane.
DISCUSSION
Thyroid hormone deiodination catalyzed by D1 generates
most of the bioactive T3 found in the circulation and thereby
plays a key role in the molecular mechanism of thyroid hor-
mone action. Although the cloning of p27 yielded a catalytically
active D1 after transient transfection (5), the subunit compo-
sition of the active enzyme, the role of individual p27 polypep-
tides in the catalytic reaction, and the physiochemical proper-
ties of the cloned enzyme have not been determined. In this
report, we describe the subunit composition of catalytically
active D1 holoenzyme, examine the role of each subunit in the
deiodination reaction, and show that the D1 dimer is sorted to
the basolateral plasma membrane of renal epithelial cells.
Prior to the cloning of p27, affinity labeling studies done with
alkylating derivatives of thyroxine were used to identify the D1
polypeptide(s). In both liver and kidney membrane prepara-
tions, a 27-kDa BrAcT4-labeled protein was identified, and this
protein showed all of the properties of the substrate binding
component of D1 as judged by rate inactivation studies (23) and
inhibitor competition studies (19, 20). Subsequent work showed
that the p27 polypeptide and the active D1 enzyme could not be
separated by gel filtration and/or isopycnic density gradient
centrifugation and that the molecular mass of the BrAcT4-
labeled D1 was 54 kDa with an s20,w of 3.7 S (28), values similar
to those determined earlier for a detergent-soluble D1 that
required reactivation by lipid reconstitution (22). In contrast,
detergent extracts of liver D1 that contained a catalytically
active proteolipid complex showed a family of active enzyme(s)
with much larger molecular weights after gel filtration (31, 32).
Thus, the constitution of the membrane-bound, functional D1
appeared to differ according to the detergent used and the
tissue source.
The finding that a catalytically active D1 enzyme assembles
from an exogenous, inert p27 and a native p27 and that the
hybrid enzyme had the same physiochemical properties as the
native D1 directly confirms that D1 is a homodimer of p27
subunits. This is consistent with the earlier work (22, 23) that
followed soluble D1 activity in crude membrane extracts. In
addition, this observation shows that native and mutant p27
subunits can combine to constitute a hybrid enzyme and re-
veals that D1 assembly is a post-translational event that
presumably depends upon the local concentration of p27 in
the membrane. Since overexpression of an exogenous p27
mutant drives the native p27 subunit into hybrid D1 mole-
cules, it appears that both the assembly and the composition
of the D1 holoenzyme can be predetermined by experimental
manipulation.
Assembly of a functional D1 holoenzyme not only requires
sufficient numbers of p27 subunits but also the correct posi-
tioning of yet to be identified dimerization domain(s). Impor-
tantly, the orientation of the native p27wt subunits in the D1
holoenzyme is constrained to a head-to-head, tail-to-tail orien-
tation by the polarity of the membrane-bound p27 subunits and
the sidedness of the catalytic activity (23, 30). This limiting
constraint imposed by the membrane-bound nature of p27 led
Larsen and co-workers (10) to conclude that residues within
the p27 membrane anchor directed either the proper folding of
the p27 or participated in catalysis. Their conclusions were
based, in part, on the failure of several p27 mutants to generate
D1 activity after transient transfection when the membrane
anchor of p27 was swapped with the endoplasmic reticulum-
derived membrane anchor(s) from the bovine 21-hydroxylase
P450 enzyme (10). The results detailed in Fig. 7 clearly show
that truncated p27 subunits lacking the membrane anchor will
bind to the native p27 and produce a functional D1 holoenzyme
in which only one p27 subunit is anchored to the membrane.
These findings indicate that the assembly of the D1 holoen-
zyme is independent of the membrane anchor. Thus, the failure
of the membrane anchor swapped p27s to assemble into a
functional enzyme (10) is likely due to the low abundance of the
exogenous p27 selenoprotein translation products after tran-
sient transfection and/or to directional miscues given by the
endoplasmic reticulum resident P450-derived membrane an-
chor. Similar caveats apply to the failure of the p27 mutants in
which the membrane anchor derived from the deiodinase fam-
ily member, type III iodothyronine 59-deiodinase, was substi-
tuted for the native membrane-spanning region to generate
catalytically active enzyme (10). Since loss of the membrane
anchor from one p27 subunit yields a hybrid D1 with activity
levels similar to that found when both enzyme subunits are
membrane-bound, it is likely that a catalytically active, “solu-
ble” D1 holoenzyme would assemble if sufficient quantities of
truncated p27 selenoprotein subunits could be produced. Un-
fortunately, the limiting quantity of SeC in mammalian cells is
likely to interfere with the synthesis of sufficient quantities of
soluble p27 selenoprotein necessary to drive assembly of a
soluble D1 holoenzyme.
With the composition of the catalytically active D1 holoen-
FIG. 8. Representative photomicrographs of S126 cells consti-
tutively expressing M4GFP. Phase contrast images of the M4GFP-
expressing (left panel) and companion fluorescence images of the same
field (right panel). Sizing bar 5 20 mm.
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zyme established, it is now possible to revisit the role of indi-
vidual amino acids in the catalytic reaction and in enzyme
assembly. For example, whereas site-directed mutagenesis was
used to identify both the SeC and His as essential enzyme
residues, these data did little to extend earlier work using more
traditional approaches of chemical modification (16, 18, 33–37).
In fact, among the histidine residues present in p27, D1 activ-
ity was completely lost by mutations of His-158 barring further
analysis of this essential residue (13). Examination of the pri-
mary amino acid sequence of p27 reveals that this residue is
located in the middle of an ;15-residue long stretch found in all
deiodinase family members from frog to man. With the ability
to predetermine the composition of D1 holoenzyme, the influ-
ence of His-158 and His-174 on catalysis and on enzyme as-
sembly can now be directly evaluated.
The ability to drive a native, catalytically active p27 subunit
into partnership with an inert p27 mutant allowed us to eval-
uate the catalytic reaction in a D1 holoenzyme in which only
one partner is functional. By using steady-state reaction kinet-
ics, we found that the hybrid D1 holoenzyme had little, if any,
change in substrate affinities but showed a 75% decrease in the
molar activity compared with wild type D1 dimer. Whether this
decrease in activity reflects an interaction between the inert
subunit and the native p27 that lowers the intrinsic catalytic
potential of the native p27 or indicates that each p27 subunit in
the D1 holoenzyme can serve as a catalytic center remains to be
established.
Based on the degeneracy of the C terminus of p27, we gen-
erated an inert p27GFP fusion protein that could be followed in
the living cell. Addition of this relatively large epitope did not
affect the ability of the fusion protein (M4GFP) to partner with
the wild type p27 in LLC-PK1 cells, and the fluorescent D1
holoenzyme showed the same catalytic properties as that for
D1 holoenzyme composed of M4 and p27wt subunits. Assuming
the same stoichiometry of p27GFP fusion protein and p27wt as
described in Table I, then ;10% of the florescent D1 dimers
were composed of an inert and active subunit, whereas 90% of
the dimers formed were composed of two fluorescent and inert
p27s. Analysis of the subcellular distribution of fluorescent D1
dimers revealed that the D1 dimers were sorted to the basolat-
eral membranes of the oriented renal epithelial cell (23, 30).
In conclusion, the data show that catalytically active D1 is a
homodimer of p27 subunits and that hybrid enzyme with only
one active subunit can catalyze deiodination by a ping-pong
reaction mechanism. Although the membrane anchor located
in the N terminus of p27 constrains the assembly of the D1
subunits into a head-to-head and tail-to-tail orientation, p27
dimerization does not require the membrane anchor, and en-
zyme assembly is a post-translational event that appears to be
driven by the local concentrations of enzyme subunits. Once
assembled the D1 holoenzyme is sorted to the plasma mem-
brane in both kidney and liver cells, where it can serve as an
enzymic barrier to the entry of the prohormone T4 and the
source of bioactive T3 for the cell.
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